A comprehensive view of pharmaceuticals/nutraceuticals. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CDMO firm Piramal Pharma Solutions opens new C$30M, 10,000 square-foot API plant in Aurora, Ontario, with two reactor suites, filtration, drying capabilities; plant capable of making highly potent APIs that require OEL of 1mcg/m3
Published: May 20, 2022 by Canada Newswire
Pfizer resists requests for research supplies of oral COVID-19 drug Paxlovid from researchers looking to lower chance of drug resistance; Pfizer to test Paxlovid-style drug later this year, as company projects US$22B in global Paxlovid sales this year
Published: May 20, 2022 by FiercePharma
Emergent BioSolutions receives exclusive global rights to Chimerix’s oral brincidofovir, including Tembexa, an FDA-approved medical countermeasure for smallpox, for US$325M; Chimerix in negotiations with BARDA for Tembexa procurement contract
Published: May 20, 2022 by Marketline - Deals
Merck signs licensing deal for Sichuan Kelun Pharmaceutical’s oncology program for areas outside of China, Hong Kong, Macao, Taiwan; deal worth US$1.4B and may relate to experimental drugs SKB264 or A166 currently in Phase 2 testing in China
Published: May 20, 2022 by SeeNews Pharmaceuticals
Novavax expects to start Phase 2 COVID-19, flu combined vaccine trial by end of 2022; initial Phase 1/2 trial data show various formulations of the combination vaccine induced immune responses in participants comparable to stand-alone shots
Published: May 19, 2022 by SeeNews Pharmaceuticals

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count